|
1
|
Yang WL, Zhang X and Lin HK: Emerging role
of Lys-63 ubiquitination in protein kinase and phosphatase
activation and cancer development. Oncogene. 29:4493–4503. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cole AJ, Clifton-Bligh RJ and Marsh DJ:
Ubiquitination and cancer: Histone H2B monoubiquitination: roles to
play in human malignancy. Endocr Relat Cancer. 22:T19–T33. 2015.
View Article : Google Scholar
|
|
3
|
Tu Y, Chen C, Pan J, Xu J, Zhou ZG and
Wang CY: The Ubiquitin Proteasome Pathway (UPP) in the regulation
of cell cycle control and DNA damage repair and its implication in
tumorigenesis. Int J Clin Exp Pathol. 5:726–738. 2012.PubMed/NCBI
|
|
4
|
Weissman AM, Shabek N and Ciechanover A:
The predator becomes the prey: Regulating the ubiquitin system by
ubiquitylation and degradation. Nat Rev Mol Cell Biol. 12:605–620.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hershko A and Ciechanover A: The ubiquitin
system for protein degradation. Annu Rev Biochem. 61:761–807. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kawadler H and Yang X: Lys63-linked
polyubiquitin chains: Linking more than just ubiquitin. Cancer Biol
Ther. 5:1273–1274. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rieser E, Cordier SM and Walczak H: Linear
ubiquitination: A newly discovered regulator of cell signalling.
Trends Biochem Sci. 38:94–102. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hussain S, Zhang Y and Galardy PJ: DUBs
and cancer: The role of deubiquitinating enzymes as oncogenes,
non-oncogenes and tumor suppressors. Cell Cycle. 8:1688–1697. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Todi SV and Paulson HL: Balancing act:
Deubiquitinating enzymes in the nervous system. Trends Neurosci.
34:370–382. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lim KH, Ramakrishna S and Baek KH:
Molecular mechanisms and functions of cytokine-inducible
deubiquitinating enzymes. Cytokine Growth Factor Rev. 24:427–431.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kouranti I, McLean JR, Feoktistova A,
Liang P, Johnson AE, Roberts-Galbraith RH and Gould KL: A global
census of fission yeast deubiquitinating enzyme localization and
interaction networks reveals distinct compartmentalization profiles
and overlapping functions in endocytosis and polarity. PLoS Biol.
8:e10004712010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bhattacharya S and Ghosh MK: Cell death
and deubiquitinases: perspectives in cancer. Biomed Res Int.
2014:4351972014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
MacGurn JA, Hsu PC and Emr SD: Ubiquitin
and membrane protein turnover: From cradle to grave. Annu Rev
Biochem. 81:231–259. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ferreira LM: Cancer metabolism: The
Warburg effect today. Exp Mol Pathol. 89:372–380. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Grüning NM, Rinnerthaler M, Bluemlein K,
Mülleder M, Wamelink MM, Lehrach H, Jakobs C, Breitenbach M and
Ralser M: Pyruvate kinase triggers a metabolic feedback loop that
controls redox metabolism in respiring cells. Cell Metab.
14:415–427. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao X, Wang H, Yang JJ, Liu X and Liu ZR:
Pyruvate kinase M2 regulates gene transcription by acting as a
protein kinase. Mol Cell. 45:598–609. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Z, Wang D, Messing EM and Wu G: VHL
protein-interacting deubiquitinating enzyme 2 deubiquitinates and
stabilizes HIF-1alpha. EMBO Rep. 6:373–378. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yasunaga J, Lin FC, Lu X and Jeang KT:
Ubiquitin-specific peptidase 20 targets TRAF6 and human T cell
leukemia virus type 1 tax to negatively regulate NF-kappaB
signaling. J Virol. 85:6212–6219. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shanmugam I, Abbas M, Ayoub F, Mirabal S,
Bsaili M, Caulder EK, Weinstock DM, Tomkinson AE, Hromas R and
Shaheen M: Ubiquitin-specific peptidase 20 regulates Rad17
stability, checkpoint kinase 1 phosphorylation and DNA repair by
homologous recombination. J Biol Chem. 289:22739–22748. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Luo W, Hu H, Chang R, Zhong J, Knabel M,
O’Meally R, Cole RN, Pandey A and Semenza GL: Pyruvate kinase M2 is
a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell.
145:732–744. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Semenza GL: Regulation of metabolism by
hypoxia-inducible factor 1. Cold Spring Harb Symp Quant Biol.
76:347–353. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim YS, Kim MS, Lee SH, Choi BC, Lim JM,
Cha KY and Baek KH: Proteomic analysis of recurrent spontaneous
abortion: Identification of an inadequately expressed set of
proteins in human follicular fluid. Proteomics. 6:3445–3454. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Choi BK, Cho YM, Bae SH, Zoubaulis CC and
Paik YK: Single-step perfusion chromatography with a throughput
potential for enhanced peptide detection by matrix-assisted laser
desorption/ionization-mass spectrometry. Proteomics. 3:1955–1961.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ramakrishna S, Suresh B, Lee EJ, Lee HJ,
Ahn WS and Baek KH: Lys-63-specific deubiquitination of SDS3 by
USP17 regulates HDAC activity. J Biol Chem. 286:10505–10514. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang W, Zheng Y, Xia Y, Ji H, Chen X, Guo
F, Lyssiotis CA, Aldape K, Cantley LC and Lu Z: ERK1/2-dependent
phosphorylation and nuclear translocation of PKM2 promotes the
Warburg effect. Nat Cell Biol. 14:1295–1304. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Perrett CA, Lin DY and Zhou D:
Interactions of bacterial proteins with host eukaryotic ubiquitin
pathways. Front Microbiol. 2:1432011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ramakrishna S, Suresh B and Baek KH: The
role of deubiquitinating enzymes in apoptosis. Cell Mol Life Sci.
68:15–26. 2011. View Article : Google Scholar
|
|
28
|
D’Arcy P, Brnjic S, Olofsson MH, et al:
Inhibition of proteasome deubiquitinating activity as a new cancer
therapy. Nat Med. 17:1636–1640. 2011. View
Article : Google Scholar
|
|
29
|
Vucic D, Dixit VM and Wertz IE:
Ubiquitylation in apoptosis: A post-translational modification at
the edge of life and death. Nat Rev Mol Cell Biol. 12:439–452.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fraile JM, Quesada V, Rodríguez D, Freije
JM and López-Otín C: Deubiquitinases in cancer: New functions and
therapeutic options. Oncogene. 31:2373–2388. 2012. View Article : Google Scholar
|
|
31
|
Mattern MR, Wu J and Nicholson B:
Ubiquitin-based anticancer therapy: Carpet bombing with proteasome
inhibitors vs surgical strikes with E1, E2, E3, or DUB inhibitors.
Biochim Biophys Acta. 1823:2014–2021. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Berthouze M, Venkataramanan V, Li Y and
Shenoy SK: The deubiquitinases USP33 and USP20 coordinate beta2
adrenergic receptor recycling and resensitization. EMBO J.
28:1684–1696. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Semenza GL: HIF-1: Upstream and downstream
of cancer metabolism. Curr Opin Genet Dev. 20:51–56. 2010.
View Article : Google Scholar :
|
